| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | IRIDEX CORP COM | 10,311 | 149,000 | 0.06% | ||
| 2 | SANOFI | 5,680 | 217,000 | 0.09% | ||
| 3 | AGILENT TECHNOLOGIES INC | 5,120 | 241,000 | 0.10% | ||
| 4 | ANTHEM INC | 2,047 | 257,000 | 0.11% | ||
| 5 | Agile Therapeutics, Inc. | 37,429 | 261,000 | 0.11% | ||
| 6 | BIO RAD LABS INC CL A | 1,675 | 274,000 | 0.12% | ||
| 7 | AETNA INC NEW | 2,604 | 301,000 | 0.13% | ||
| 8 | ST JUDE | 3,911 | 312,000 | 0.13% | ||
| 9 | HUMANA | 1,768 | 313,000 | 0.13% | ||
| 10 | PFIZER INC | 10,520 | 356,000 | 0.15% | ||
| 11 | ASTRAZENECA PLC | 11,360 | 373,000 | 0.16% | ||
| 12 | MYLAN N V | 9,775 | 373,000 | 0.16% | ||
| 13 | AMGEN INC | 2,330 | 389,000 | 0.17% | ||
| 14 | MERCK & CO INC | 6,610 | 413,000 | 0.18% | ||
| 15 | LILLY ELI & CO | 5,495 | 441,000 | 0.19% | ||
| 16 | BRISTOL MYERS SQUIBB CO | 8,290 | 447,000 | 0.19% | ||
| 17 | CELGENE CORP | 4,280 | 447,000 | 0.19% | ||
| 18 | UNITED THERAPEUTICS | 3,820 | 451,000 | 0.19% | ||
| 19 | JOHNSON & JOHNSON | 3,820 | 451,000 | 0.19% | ||
| 20 | AVINGER INC | 96,600 | 461,000 | 0.20% | ||
| 21 | STERIS PLC SHS USD | 6,330 | 463,000 | 0.20% | ||
| 22 | ALLERGAN PLC | 2,035 | 469,000 | 0.20% | ||
| 23 | NOVARTIS A G | 6,070 | 479,000 | 0.21% | ||
| 24 | SPDR SER TR | 7,590 | 503,000 | 0.22% | ||
| 25 | CHEMBIO DIAGNOSTICS INC COM NEW | 78,023 | 577,000 | 0.25% | ||
| 26 | BECTON DICKINSON & CO | 3,395 | 610,000 | 0.26% | ||
| 27 | BIOTELEMETRY INC COM | 94,993 | 1,764,000 | 0.76% | ||
| 28 | QUIDEL CORP COM | 81,700 | 1,805,000 | 0.78% | ||
| 29 | IONIS PHARMACEUTICALS INC | 50,782 | 1,861,000 | 0.80% | ||
| 30 | RTI SURGICAL HOLDINGS INC COM | 598,854 | 1,874,000 | 0.81% | ||
| 31 | VERTEX PHARMACEUT | 23,310 | 2,033,000 | 0.88% | ||
| 32 | NANOSTRING TECHNOLOGIES INC | 115,860 | 2,315,000 | 1.00% | ||
| 33 | TEARLAB CORP | 3,614,245 | 2,349,000 | 1.01% | ||
| 34 | BIO TECHNE CORP | 23,738 | 2,599,000 | 1.12% | ||
| 35 | ALKERMES PLC SHS | 60,680 | 2,854,000 | 1.23% | ||
| 36 | BIOMARIN | 31,912 | 2,952,000 | 1.27% | ||
| 37 | CEPHEID | 60,805 | 3,204,000 | 1.38% | ||
| 38 | IMMUNOMEDICS INC | 992,867 | 3,227,000 | 1.39% | ||
| 39 | STREAMLINE HEALTH SOLUTIONS COM | 1,760,301 | 3,239,000 | 1.39% | ||
| 40 | PHYSICIANS RLTY TR | 152,365 | 3,282,000 | 1.41% | ||
| 41 | ENDOLOGIX INC | 256,906 | 3,288,000 | 1.42% | ||
| 42 | LEMAITRE VASCULAR INC COM | 182,634 | 3,623,000 | 1.56% | ||
| 43 | SHIRE PLC | 19,598 | 3,799,000 | 1.64% | ||
| 44 | LIGAND PHARMACEUTICALS INC | 41,177 | 4,203,000 | 1.81% | ||
| 45 | SAGE THERAPEUTICS | 94,037 | 4,330,000 | 1.86% | ||
| 46 | VERACYTE INC | 573,779 | 4,366,000 | 1.88% | ||
| 47 | ARATANA THERAPEUTICS INC COM | 467,743 | 4,378,000 | 1.89% | ||
| 48 | Model N Inc | 395,166 | 4,390,000 | 1.89% | ||
| 49 | BLUEBIRD BIO INCORPORATED | 67,545 | 4,578,000 | 1.97% | ||
| 50 | MEDICINES CO | 126,024 | 4,756,000 | 2.05% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-16-007989, filed 2016.11.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
